TrialHepatology (Baltimore, Md.)2013

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study.

Michael W Fried et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.